290 related articles for article (PubMed ID: 24535909)
1. Drug resistance analysis of bacterial strains isolated from burn patients.
Wang LF; Li JL; Ma WH; Li JY
Genet Mol Res; 2014 Jan; 13(4):9727-34. PubMed ID: 24535909
[TBL] [Abstract][Full Text] [Related]
2. Changes in bacterial isolates from burn wounds and their antibiograms: a 20-year study (1986-2005).
Guggenheim M; Zbinden R; Handschin AE; Gohritz A; Altintas MA; Giovanoli P
Burns; 2009 Jun; 35(4):553-60. PubMed ID: 19167827
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of distribution characteristics and drug resistance of 2748 strains of pathogens isolated from burn patients].
Peng DZ; Liu XL; Liu ZY; Shu WT; Zhou X; Liu J; Huang YS; Wu J; Fu WL
Zhonghua Shao Shang Za Zhi; 2012 Apr; 28(2):87-95. PubMed ID: 22781318
[TBL] [Abstract][Full Text] [Related]
4. [Bacteriological surveillance in a burn intensive care unit and the analysis of bacterial resistance to antibiotics].
Chen L; Deng SL; Liang JW; Zhang YH; Liu JW
Zhonghua Shao Shang Za Zhi; 2005 Aug; 21(4):270-2. PubMed ID: 16185410
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of predominant bacteria of burn infection and their resistance to antibiotics in recent years].
Li M; Zhang GA; Liu Y
Zhonghua Shao Shang Za Zhi; 2007 Apr; 23(2):91-3. PubMed ID: 17649879
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of multidrug-resistant organisms recovered at a military burn center.
Keen EF; Robinson BJ; Hospenthal DR; Aldous WK; Wolf SE; Chung KK; Murray CK
Burns; 2010 Sep; 36(6):819-25. PubMed ID: 20080354
[TBL] [Abstract][Full Text] [Related]
7. [An investigation of bacterial ecology and analysis of bacterial resistance to antibiotics in a burn ward in Nanning district].
Li HM; Liang ZQ; Liu DE; Meng CY
Zhonghua Shao Shang Za Zhi; 2005 Apr; 21(2):107-10. PubMed ID: 15938956
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of 728 strains of infectious bacteria in burn ward and analysis of their antibiotic resistance].
Deng JJ; Wei LH; Zou FM; Si XQ; Liu G; Gao YX; Liu J
Zhonghua Shao Shang Za Zhi; 2007 Dec; 23(6):420-3. PubMed ID: 18457252
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
Rossolini GM; Mantengoli E
Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
[TBL] [Abstract][Full Text] [Related]
10. Survey of the susceptibility of urinary isolates to antibacterial agents in 2003.
Ishikawa K; Hayakawa S; Miyakawa S; Kusaka M; Shiroki R; Hoshinaga K
J Infect Chemother; 2005 Feb; 11(1):44-7. PubMed ID: 15729488
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem.
Koga T; Abe T; Inoue H; Takenouchi T; Kitayama A; Yoshida T; Masuda N; Sugihara C; Kakuta M; Nakagawa M; Shibayama T; Matsushita Y; Hirota T; Ohya S; Utsui Y; Fukuoka T; Kuwahara S
Antimicrob Agents Chemother; 2005 Aug; 49(8):3239-50. PubMed ID: 16048932
[TBL] [Abstract][Full Text] [Related]
13. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
[TBL] [Abstract][Full Text] [Related]
14. Bacteriologic profile and antibiogram of blood culture isolates from a children's hospital in Kabul.
Tariq TM
J Coll Physicians Surg Pak; 2014 Jun; 24(6):396-399. PubMed ID: 24953929
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of resistance tendency of bloodstream-infecting pathogens in China].
Lü Y; Li Y; Xue F; Zhang XZ; Hu YJ; Jin YF; Chu YZ; Hu ZD; Zhao JH; Pan SY; Zhao WS; Hu BJ; Yu YS; Deng QL; Yang J; Li Y; Liu WE; Lü XJ; Yang YJ; Zhou L; Dong F; Fu WL; Xu XL; Pei FY; Yang B; Meng L; Ji P; Wang S
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):411-9. PubMed ID: 24103203
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of tigecycline against resistant micro-organisms isolated from burn patients.
Timurkaynak F; Arslan H; Azap OK; Senger SS; Başaran O; Karaman SO; Haberal M
Burns; 2008 Nov; 34(7):1033-6. PubMed ID: 18539397
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo antibacterial activities of SM-216601, a new broad-spectrum parenteral carbapenem.
Ueda Y; Kanazawa K; Eguchi K; Takemoto K; Eriguchi Y; Sunagawa M
Antimicrob Agents Chemother; 2005 Oct; 49(10):4185-96. PubMed ID: 16189097
[TBL] [Abstract][Full Text] [Related]
18. Common pathogens in burn wound and changes in their drug sensitivity.
Rezaei E; Safari H; Naderinasab M; Aliakbarian H
Burns; 2011 Aug; 37(5):805-7. PubMed ID: 21388742
[TBL] [Abstract][Full Text] [Related]
19. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
Xiao QZ; Su DH; Jiang JH; Zhong NS
Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
[TBL] [Abstract][Full Text] [Related]
20. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
Dowzicky MJ; Park CH
Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
